The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden von Jendle, Johan, Buompensiere, M. I., Holm, A. L., de Portu, S., Malkin, S. J. P., Cohen, O.

Volltext

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Swe... von Jendle, J., Buompensiere, M. I., Holm, A. L., de Portu, S., Malkin, S. J. P., Cohen, O.

Volltext

COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 780G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE 1 DI... von Cohen, O., Holm, A. Ledgaard, Buompensiere, M. I., Jendle, Johan

Volltext

COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 780G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIA... von Jendle, J, Buompensiere, M. I., Saltik, A. Z. Ozdemir, Cohen, O.

Volltext

EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents von Hoffmann, Luisa, Kohls, Mirjam, Arnolds, Stefanie, Achenbach, Peter, Bergholdt, Regine, Bonifacio, Ezio, Bosi, Emanuele, Gündert, Melanie, Hoefelschweiger, Bianca K, Hummel, Sandra, Jarosz-Chobot, Przemysława, Kordonouri, Olga, Lampasona, Vito, Narendran, Parth, Overbergh, Lut, Pociot, Flemming, Raposo, João Filipe, Šumník, Zdeněk, Szypowska, Agnieszka, Vercauteren, Jurgen, Winkler, Christiane, Mathieu, Chantal, Ziegler, Anette-Gabriele, Mathieu, C, Gillard, P, Casteels, K, van der Schueren, B, Overbergh, L, Vercauteren, J, Ziegler, A G, Achenbach, P, Haupt, F, Winkler, C, Hummel, S, Pieber, T, Mader, J, Moitzi, S, Del Prato, S, Torbeyns, B, Sumnik, Z, Cinek, O, Neuman, V, Berka, B, Pociot, F, Petersen, B, Antvorskov, J, Klaebel, J H, Lahesmaa, R, Hyöty, H, Laiho, J E, Reschke, F, Kordonouri, O, von dem Berge, T, Bonifacio, E, Berner, R, Hommel, A, Loff, A, Gemulla, G, Zubizarreta, N, Bosi, E, Piemonti, L, Lampasona, V, Dotta, F, Sebastiani, G, Szypowska, A, Karczewski, K, Jarosz-Chobot, P, Raposo, J F, Ribeiro, R, Coelho, R, Peakman, M, Niemoeller, E, Baccara-Dinet, M, Van Rampelbergh, J, Bergholdt, R, Fogh, K, Cohen, O, Buompensiere, M I, Hurtado del Pozo, C, Latres, E, Agiostratidou, G, Koralova, A

Volltext

EE535 Cost-Utility Analysis of an Advanced Hybrid Closed-Loop System vs Multiple Daily Injection Therapy With Intermittently Scanned Continuous Glucose Monitoring in People With Ty... von Ozdemir Saltik, AZ, Jadat, C, Koch, P, Buompensiere, MI, Yu, J, de Portu, S, Cohen, O

Volltext

EE139 Short-Term Economic Benefits of and Advanced Hybrid Closed-Loop System in People With Type 1 Diabetes and Above-Target HBA1C in France von Ozdemir Saltik, AZ, Jadat, C, Koch, P, Buompensiere, MI, Yu, J, de Portu, S, Cohen, O

Volltext

EE783 Cost-Effectiveness Analysis of an Advanced Hybrid Closed Loop System Versus Standard of Care in the Management of Type 1 Diabetes in the Netherlands von Serné, EH, Buompensiere, MI, Ozdemir Saltik, AZ, Yu, J, de Portu, S, Cohen, O

Volltext